The PMWC 2020 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.
Confirmed Presenting Companies:
Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and currently carries out a variety of projects in the areas of genomics and proteomics both in yeast and humans. These include the large-scale analysis of proteins using protein microarrays and the global mapping of the binding sites of chromosomal proteins. His laboratory built the first proteome chip for any organism and the first high resolution tiling array for the entire human genome.
Dr. Tim Bauer is the Vice President, Head of Clinical Science at Everlywell, the digital health company poised to disrupt the 25 billion dollar lab testing industry by providing consumers with at-home lab testing kits that include insightful, easy-to-understand results. Prior to joining Everlywell, Dr. Bauer held leadership and senior clinical scientist positions at biotechnology companies such as SomaLogic and Gilead Sciences. An expert in clinical research with over two decades of experience, he also spent several years developing clinical trials for CPC Clinical Research. Dr Bauer continues to serve as an adjunct faculty and researcher at the University of Colorado School of Medicine, where he has received research grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Bauer earned a Ph.D. in Physiology from Kansas State University and a B.S. and M.S. in Exercise Physiology from Colorado State University. He continued his clinical research training at the University of Colorado School of Medicine, where he completed post-doctoral fellowships in Cardiology and Endocrinology. He resides in Austin, Texas.
Health Monitoring Showcase:
Everlywell is a digital health company that provides consumers with access to a suite over validated at-home lab testing kits that include insightful, easy-to-understand results. The company was founded in 2015 and is based in Austin, Texas.
Consumer Testing And Precision Medicine: Past, Present, And Future
Combining genotypic and phenotypic data to provide tailored healthcare is the vision of precision medicine, yet the testing industry was quicker to bring consumer genomics to market than consumer testing for basic biomarkers such as hormones, vitamins, and markers associated with chronic conditions. This session will discuss the past, present and future of precision medicine using this lens.
As a Chief Executive in both public and private companies, Scott has championed data and insight models that foster an exchange of meaningful value between the collectors of data and the people from whom they collect it. As an investor in DataSpeaks, Scott sees the application of SIMA as the next inflection point in that mission.
Health Monitoring Showcase:
DataSpeaks, an early stage software company, computes precision quantitative time-dependent phenotypes – From Genomes to Health (TM).
Complex Adaptive Systems Metrology For Precision Medicine
Precision health and medicine must monitor causal health effects, not just health, for individuals, not just group-average differences, because no one is average. DataSpeaks’ proprietary Science of Individuality Measurement Algorithm (SIMA) processes monitoring data to compute actionable phenotypes for personalization and learning what genetic differences mean.
Michael Brammer launched FamGenix in 2019, a platform designed to allow patients to record and manage their family health histories and ultimately share this data with healthcare providers. The platform consists of an App patients can download for both iPhone and Android devices for free, and a clinician portal for healthcare providers. The FamGenix App will identify patients who are at an increased risk of hereditary cancers and meet referral criteria for genetic counseling based on NCCN and ACMG guidelines. In 1996, Brammer co-founded Progeny Software. As CEO, he guided the company to accumulating over 2000 customers in more than 80 countries, providing software tools to assist researchers and clinicians in gathering and managing family health histories. In 2015, Brammer sold the company to Ambry Genetics and as CEO, spent 2 years transitioning operations over to them.
Health Monitoring Showcase:
FamHis, Inc. is the developer of the FamGenix platform, where patients record and manage their family health histories.
Precision Medicine begins with Family Health Histories
One of the most accurate predictors of a person’s overall risks of developing a disease is their family health history. FamGenix is a platform built based on feedback from researchers and clinicians worldwide striving to accurately record family health histories.
Elias is working with his global teams and partners to make the world a healthier place through science and technology. He is expanding knowledge of how Biostrap can fulfill its mission of providing the world's most advanced, science-based platform to improve global health. Additionally, Biostrap is committed to increasing understanding of wearables and biometrics in general, to all stakeholders in the wellness, fitness and medical fields. As a thought-leader in the field, Elias has presented at various conferences and participated in panels across medical technology and health optimization, such as the Transformative Technology Conference, the Interrupt MedTech Summit LA 2019 and the UFC Performance Institute. Elias is also the Executive Director of the Biohackers Collective and the founder of Business Brain assisting businesses in their leadership and business strategy.
Health Monitoring Showcase:
Biostrap is on a mission to provide the world's most advanced, science-based platform to improve global health. Biostrap is currently building an ecosystem of partners to provide and use data to gather insights to one's health.
How Healthcare Personalization And Data Analytics Are Transforming Telemedicine
Discoveries in the biosciences are driving the personalization of medicine. Simultaneously technology is opening up new avenues to communicate with patients via telemedicine. Biostrap is providing biometric insights that can make patient monitoring more effective while lowering costs and improving patient care.
Russ is focused on scaling growth at Glooko, a diabetes digital technology company, in 9000+ clinics and 24 countries. Glooko provides actionable insights to empower people with diabetes and the people who care for them. Part of a data technology platform, Glooko’s mobile app automatically syncs data from diabetes devices including blood glucose meters, insulin pumps, CGMs, smart insulin pens, and fitness trackers – enabling people with diabetes and clinicians to correlate data with diet, exercise, and medication, remotely or in the clinic. Glooko provides clinicians an office data upload solution and population health capabilities, plus integration into EHRs. An experienced healthcare business strategist with deep customer experience, Russ brings a wealth of market knowledge to Glooko. Prior to Glooko, Russ held executive healthcare positions, most recently as Chief Operating Officer at ShareCare, a health and wellness engagement platform providing personalized resources and as Chief Client Officer at OptumHealth.